ARTICLE | Clinical News
AC625 amylin blocker: Filed IND
January 17, 1994 8:00 AM UTC
Amylin Pharmaceuticals Inc. (AMLN) San Diego Product: AC625 amylin blocker Indication: Hypertension associated with obesity and insulin resistance Status: Filed IND ...